Skip to main content
Copenhagen48

About us

Our purpose is to save lives by supplying anti-infective therapies to the world

Our goal is to expand our world leadership in lifecycle management of fermentation-based, non-beta-lactam anti-infectives to sustainably provide these treatments to patients around the world

Copenhagen56

Meet the Xellia Executive Committee and our Board of Directors

Leadership teams

Xellia Pharmaceuticals is wholly owned by Novo Holdings A/S since 2013.

Heritage 1940-1960

More than 120 years of experience in the pharmaceutical industry

Our heritage

Xellia is a world leader in delivering critical care therapies and anti-infective solutions for severe and often life-threatening infections, encompassing Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs).

Copenhagen40

Join our team

The “all hands on deck” workplace.

At Xellia, you get a rare opportunity. The chance to shape yourself, our company and society.